Skip to main content
main-content
Erschienen in: Endocrine 3/2022

07.09.2022 | Original Article

Identification of the collagen family as prognostic biomarkers in papillary thyroid carcinoma

verfasst von: Juntao Niu, Wenyu Guo, Yu-Zhou Chen, Ning Jiang

Erschienen in: Endocrine | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to construct a collagen-related prognostic model for thyroid cancer and to investigate prognostic value of collagen family genes for thyroid cancer.

Methods

A LASSO Cox regression model for thyroid cancer was developed based on the expression profiles of collagen-related genes. Kaplan–Meier survival analysis was performed for high and low risk groups. The ROC method was used to assess its predictive performance. Predictive independence was verified by multivariate Cox regression analysis. The relationship between this feature and immune cell infiltration was analyzed by tumor microenvironment. COL18A1 was validated by immunohistochemistry and RT-PCR in thyroid cancer tissues. The effect of COL18A1 on cell proliferation, migration and invasion ability of tumor cells were further valuated by CCK-8 assay and transwell assay. The effect of COL18A1 on the immune escape ability of tumor cells was further valuated by cytotoxicity assays.

Results

A model including 4 collagen family genes was developed to predict thyroid cancer prognosis. Patients with high-risk score had a poorer prognosis than those with low-risk scores for 1-, 2-, 3-, and 5- year survival. The model independently predicted prognosis after adjusting for other prognostic factors. A nomogram combining risk score and age was constructed with high sensitivity and specificity. This feature was significantly associated with immune cell infiltration. COL18A1 was aberrantly over-expressed in thyroid cancer compared with control tissues and significantly increased proliferative capacity, migration capacity, invasion capacity, and immune escape ability of tumor cells.

Conclusion

Our findings establish a signature associated with collagen family genes that can be a promising tool to predict the prognosis of thyroid cancer. High COL18A1 expression significantly correlates with the poor prognosis of patients and enhances the immune escape ability of tumor cells.
Literatur
1.
Zurück zum Zitat C.D. Seib, J.A. Sosa, Evolving understanding of the epidemiology of thyroid cancer. Endocrinol. Metab. Clin. North Am., 48(1), 23-+ (2019) CrossRef C.D. Seib, J.A. Sosa, Evolving understanding of the epidemiology of thyroid cancer. Endocrinol. Metab. Clin. North Am., 48(1), 23-+ (2019) CrossRef
2.
Zurück zum Zitat R.C. Mould et al. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission. Endocr.-Relat. Cancer 24(12), T311–T329 (2017) PubMedCrossRef R.C. Mould et al. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission. Endocr.-Relat. Cancer 24(12), T311–T329 (2017) PubMedCrossRef
3.
Zurück zum Zitat Y. Bai, K. Kakudo, Y. Li, Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type ( vol 99, pg 1908, 2008). Cancer Sci. 99(12), 2548 (2008) Y. Bai, K. Kakudo, Y. Li, Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type ( vol 99, pg 1908, 2008). Cancer Sci. 99(12), 2548 (2008)
4.
Zurück zum Zitat T.R. Cox, J.T. Erler, Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Models Mechanisms 4(2), 165–178 (2011) CrossRef T.R. Cox, J.T. Erler, Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Models Mechanisms 4(2), 165–178 (2011) CrossRef
5.
Zurück zum Zitat P. Friedl, K. Wolf, Tube travel: The role of proteases in individual and collective a cancer cell invasion. Cancer Res. 68(18), 7247–7249 (2008) PubMedCrossRef P. Friedl, K. Wolf, Tube travel: The role of proteases in individual and collective a cancer cell invasion. Cancer Res. 68(18), 7247–7249 (2008) PubMedCrossRef
6.
Zurück zum Zitat P.G. Gritsenko, O. Ilina, P. Friedl, Interstitial guidance of cancer invasion. J. Pathol. 226(2), 185–199 (2012) PubMedCrossRef P.G. Gritsenko, O. Ilina, P. Friedl, Interstitial guidance of cancer invasion. J. Pathol. 226(2), 185–199 (2012) PubMedCrossRef
8.
Zurück zum Zitat N.K. Karamanos et al. Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 75–76, 1–11 (2019) PubMedCrossRef N.K. Karamanos et al. Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 75–76, 1–11 (2019) PubMedCrossRef
9.
Zurück zum Zitat N.K. Karamanos et al. Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics. Chem. Rev. 118(18), 9152–9232 (2018) PubMedCrossRef N.K. Karamanos et al. Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics. Chem. Rev. 118(18), 9152–9232 (2018) PubMedCrossRef
10.
Zurück zum Zitat N. Afratis et al. Glycosaminoglycans: key players in cancer cell biology and treatment. Febs J. 279(7), 1177–1197 (2012) PubMedCrossRef N. Afratis et al. Glycosaminoglycans: key players in cancer cell biology and treatment. Febs J. 279(7), 1177–1197 (2012) PubMedCrossRef
11.
Zurück zum Zitat A.D. Theocharis, D. Manou, N.K. Karamanos, The extracellular matrix as a multitasking player in disease. Febs J. 286(15), 2830–2869 (2019) PubMedCrossRef A.D. Theocharis, D. Manou, N.K. Karamanos, The extracellular matrix as a multitasking player in disease. Febs J. 286(15), 2830–2869 (2019) PubMedCrossRef
14.
Zurück zum Zitat M.W. Conklin et al. Collagen alignment as a predictor of recurrence after ductal carcinoma in situ. Cancer Epidemiol. Biomark. Prev. 27(2), 138–145 (2018) CrossRef M.W. Conklin et al. Collagen alignment as a predictor of recurrence after ductal carcinoma in situ. Cancer Epidemiol. Biomark. Prev. 27(2), 138–145 (2018) CrossRef
15.
Zurück zum Zitat M.W. Conklin et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178(3), 1221–1232 (2011) PubMedPubMedCentralCrossRef M.W. Conklin et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Pathol. 178(3), 1221–1232 (2011) PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat K.B. Pointer et al. Association of collagen architecture with glioblastoma patient survival. J. Neurosurg. 126(6), 1812–1821 (2017) PubMedCrossRef K.B. Pointer et al. Association of collagen architecture with glioblastoma patient survival. J. Neurosurg. 126(6), 1812–1821 (2017) PubMedCrossRef
17.
Zurück zum Zitat M.F. Penet et al. Structure and function of a prostate cancer dissemination-permissive extracellular matrix. Clin. Cancer Res. 23(9), 2245–2254 (2017) PubMedCrossRef M.F. Penet et al. Structure and function of a prostate cancer dissemination-permissive extracellular matrix. Clin. Cancer Res. 23(9), 2245–2254 (2017) PubMedCrossRef
18.
Zurück zum Zitat R. Hristu et al. Quantitative second harmonic generation microscopy for the structural characterization of capsular collagen in thyroid neoplasms. Biomed. Opt. Express 9(8), 3923–3936 (2018) PubMedPubMedCentralCrossRef R. Hristu et al. Quantitative second harmonic generation microscopy for the structural characterization of capsular collagen in thyroid neoplasms. Biomed. Opt. Express 9(8), 3923–3936 (2018) PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat T. Li et al. CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma. Cancer Biol. Med 17(2), 357–370 (2020) PubMedPubMedCentralCrossRef T. Li et al. CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma. Cancer Biol. Med 17(2), 357–370 (2020) PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat K.M. Mak, C.Y.M. Png, D.J. Lee, Type V collagen in health, disease, and fibrosis. Anat. Rec.-Adv. Integr. Anat. Evolut. Biol. 299(5), 613–629 (2016) CrossRef K.M. Mak, C.Y.M. Png, D.J. Lee, Type V collagen in health, disease, and fibrosis. Anat. Rec.-Adv. Integr. Anat. Evolut. Biol. 299(5), 613–629 (2016) CrossRef
21.
Zurück zum Zitat T. Nardo et al. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells. Tumor Biol. 35(10), 9949–9955 (2014) CrossRef T. Nardo et al. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells. Tumor Biol. 35(10), 9949–9955 (2014) CrossRef
22.
Zurück zum Zitat S.H. Barsky et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am. J. Pathol. 108(3), 276–283 (1982) PubMedPubMedCentral S.H. Barsky et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am. J. Pathol. 108(3), 276–283 (1982) PubMedPubMedCentral
23.
Zurück zum Zitat H. Fischer et al. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 22(6), 875–878 (2001) PubMedCrossRef H. Fischer et al. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 22(6), 875–878 (2001) PubMedCrossRef
24.
Zurück zum Zitat S. Berchtold et al. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Cancer Lett. 356(2), 721–732 (2015) PubMedCrossRef S. Berchtold et al. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Cancer Lett. 356(2), 721–732 (2015) PubMedCrossRef
25.
Zurück zum Zitat W.B. Liu et al. COL5A1 may contribute the metastasis of lung adenocarcinoma. Gene 665, 57–66 (2018) PubMedCrossRef W.B. Liu et al. COL5A1 may contribute the metastasis of lung adenocarcinoma. Gene 665, 57–66 (2018) PubMedCrossRef
26.
Zurück zum Zitat G. Feng et al. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res 11, 1263–1274 (2019) PubMedPubMedCentralCrossRef G. Feng et al. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res 11, 1263–1274 (2019) PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat W. Ren et al. Overexpression of collagen type V alpha1 chain in human breast invasive ductal carcinoma is mediated by TGF-beta1. Int J. Oncol. 52(5), 1694–1704 (2018) PubMed W. Ren et al. Overexpression of collagen type V alpha1 chain in human breast invasive ductal carcinoma is mediated by TGF-beta1. Int J. Oncol. 52(5), 1694–1704 (2018) PubMed
28.
Zurück zum Zitat M.S. O’Reilly et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2), 277–285 (1997) PubMedCrossRef M.S. O’Reilly et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2), 277–285 (1997) PubMedCrossRef
29.
Zurück zum Zitat N. Yamaguchi et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18(16), 4414–4423 (1999) PubMedPubMedCentralCrossRef N. Yamaguchi et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18(16), 4414–4423 (1999) PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat M. Dhanabal et al. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274(17), 11721–11726 (1999) PubMedCrossRef M. Dhanabal et al. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274(17), 11721–11726 (1999) PubMedCrossRef
31.
Zurück zum Zitat D.K. Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 105(3), 1044–1051 (2005) PubMedCrossRef D.K. Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 105(3), 1044–1051 (2005) PubMedCrossRef
32.
Zurück zum Zitat G. Schuch et al. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 63(23), 8345–8350 (2003) PubMed G. Schuch et al. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 63(23), 8345–8350 (2003) PubMed
33.
Zurück zum Zitat P. Hagg et al. Type XIII collagen is identified as a plasma membrane protein. J. Biol. Chem. 273(25), 15590–15597 (1998) PubMedCrossRef P. Hagg et al. Type XIII collagen is identified as a plasma membrane protein. J. Biol. Chem. 273(25), 15590–15597 (1998) PubMedCrossRef
34.
Zurück zum Zitat P. Hagg et al. Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol. 19(8), 727–742 (2001) PubMedCrossRef P. Hagg et al. Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol. 19(8), 727–742 (2001) PubMedCrossRef
35.
Zurück zum Zitat M. Yi, J.E. Schnitzer, Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc. Natl Acad. Sci. USA 106(42), 17886–17891 (2009) PubMedPubMedCentralCrossRef M. Yi, J.E. Schnitzer, Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc. Natl Acad. Sci. USA 106(42), 17886–17891 (2009) PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat S. Nallanthighal, J.P. Heiserman, and D.J. Cheon, Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer. Cancers (Basel), 13(5), (2021) S. Nallanthighal, J.P. Heiserman, and D.J. Cheon, Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer. Cancers (Basel), 13(5), (2021)
37.
Zurück zum Zitat F. Vazquez-Villa et al. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression. Tumor Biol. 36(4), 2213–2222 (2015) CrossRef F. Vazquez-Villa et al. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression. Tumor Biol. 36(4), 2213–2222 (2015) CrossRef
38.
Zurück zum Zitat Z. Raglow, S.M. Thomas, Tumor matrix protein collagen XI alpha 1 in cancer. Cancer Lett. 357(2), 448–453 (2015) PubMedCrossRef Z. Raglow, S.M. Thomas, Tumor matrix protein collagen XI alpha 1 in cancer. Cancer Lett. 357(2), 448–453 (2015) PubMedCrossRef
39.
Zurück zum Zitat P.M. Angel, S.C. Zambrzycki, Predictive value of collagen in cancer. Adv. Cancer Res 154, 15–45 (2022) PubMedCrossRef P.M. Angel, S.C. Zambrzycki, Predictive value of collagen in cancer. Adv. Cancer Res 154, 15–45 (2022) PubMedCrossRef
40.
Zurück zum Zitat A.C. Martins Cavaco et al. Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis. Cancer Metastasis Rev. 39(3), 603–623 (2020) PubMedCrossRef A.C. Martins Cavaco et al. Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis. Cancer Metastasis Rev. 39(3), 603–623 (2020) PubMedCrossRef
41.
Zurück zum Zitat X.P. Shen et al. Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J. Clin. Oncol. 36(5), 438-+ (2018) PubMedCrossRef X.P. Shen et al. Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J. Clin. Oncol. 36(5), 438-+ (2018) PubMedCrossRef
42.
43.
Zurück zum Zitat S. Kauppila et al. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J. Pathol. 186(3), 262–268 (1998) PubMedCrossRef S. Kauppila et al. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J. Pathol. 186(3), 262–268 (1998) PubMedCrossRef
44.
Zurück zum Zitat M.A. Wozniak et al. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 163(3), 583–595 (2003) PubMedPubMedCentralCrossRef M.A. Wozniak et al. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 163(3), 583–595 (2003) PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat G. Kaplan, G. Gaudernack, In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med 156(4), 1101–14. (1982) PubMedCrossRef G. Kaplan, G. Gaudernack, In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J. Exp. Med 156(4), 1101–14. (1982) PubMedCrossRef
46.
Zurück zum Zitat N.G. Nicolson et al. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis. Surgery 167(1), 66–72 (2020) PubMedCrossRef N.G. Nicolson et al. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis. Surgery 167(1), 66–72 (2020) PubMedCrossRef
Metadaten
Titel
Identification of the collagen family as prognostic biomarkers in papillary thyroid carcinoma
verfasst von
Juntao Niu
Wenyu Guo
Yu-Zhou Chen
Ning Jiang
Publikationsdatum
07.09.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03175-9

Weitere Artikel der Ausgabe 3/2022

Endocrine 3/2022 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.